Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL2701657 | 1.00 | THRB (0.35) | THRBALDH1A1TP53CYP3A4MAPK1 | |
| Methacrylic Acid SCHEMBL6740567 | 0.94 | THRB (0.32) | THRBALDH1A1TP53CYP3A4MAPK1 | |
| Methacrylic Acid SCHEMBL28074211 | 0.93 | THRB (0.31) | THRB | |
| Methacrylic Acid SCHEMBL29155230 | 0.91 | ALDH1A1 (0.36) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| Acetic Acid SCHEMBL11582719 | 0.91 | THRB (0.38) | THRBALDH1A1TP53CYP3A4MAPK1 | |
| Methacrylic Acid SCHEMBL8059435 | 0.90 | THRB (0.40) | THRBALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL27869348 | 0.87 | THRB (0.33) | THRBALDH1A1TP53CYP3A4MAPK1 | |
| Acrylic Acid SCHEMBL7578570 | 0.86 | THRB (0.40) | THRBALDH1A1TP53CYP3A4MAPK1 | |
| Methacrylic Acid SCHEMBL8940713 | 0.86 | THRB (0.37) | THRBALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL38754 | 0.86 | MEN1 (0.38) | THRBALDH1A1TP53CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510738-A | Impact modifier for resin and preparation method thereof | 山东金昌树新材料股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-117402300-A | Organosilicon-containing impact modifier for resin and preparation method thereof | 山东金昌树新材料股份有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-117384324-A | Anti-whitening modifier for resin and preparation method thereof | 山东金昌树新材料股份有限公司 | 2024-01-12 | — | — | CN | claimed |
| US-11643495-B2 | Acrylic emulsions modified with functional (meth)acrylates to enable crosslinking | Miwon North America Incorporated (US) | 2023-05-09 | — | — | US | claimed |
| US-11155685-B2 | Acrylic emulsions modified with functional (meth)acrylates to enable crosslinking | Miwon North America Incorporated (US) | 2021-10-26 | — | — | US | claimed |
| EP-3474952-B1 | COMPOSITIONS CONTAINING LATEX PARTICLES AND UV ABSORBERS | ROHM & HAAS (US) | 2021-07-28 | — | — | EP | claimed |
| EP-3681962-A1 | ACRYLIC EMULSIONS MODIFIED WITH FUNCTIONAL (METH)ACRYLATES TO ENABLE CROSSLINKING | Miwon North America Incorporated (US) | 2020-07-22 | — | — | EP | claimed |
| US-10507174-B2 | Skin care compositions | ROHM AND HAAS COMPANY (US) | 2019-12-17 | — | — | US | claimed |
| US-20190133913-A1 | COMPOSITIONS CONTAINING LATEX PARTICLES AND UV ABSORBERS | ROHM & HAAS (US) | 2019-05-09 | — | — | US | claimed |
| WO-2019075037-A1 | ACRYLIC EMULSIONS MODIFIED WITH FUNCTIONAL (METH)ACRYLATES TO ENABLE CROSSLINKING | Miwon North America Incorporated (US) | 2019-04-18 | — | — | WO | claimed |
| US-20190112435-A1 | Acrylic Emulsions Modified with Functional (Meth)acrylates to Enable Crosslinking | Miwon North America Incorporated (US) | 2019-04-18 | — | — | US | claimed |
| CN-117510738-A | Impact modifier for resin and preparation method thereof | 山东金昌树新材料股份有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117402300-A | Organosilicon-containing impact modifier for resin and preparation method thereof | 山东金昌树新材料股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-117384324-A | Anti-whitening modifier for resin and preparation method thereof | 山东金昌树新材料股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-20230357474-A1 | Acrylic Emulsions Modified with Functional (Meth)acrylates to Enable Crosslinking | Miwon North America Incorporated (US) | 2023-11-09 | — | — | US | disclosed |
| US-4592816-A | Forming negative images on conductive surfaces | ROHM AND HAAS COMPANY (US) | 1986-06-03 | — | — | US | disclosed |
| EP-0176356-A2 | Photosensitive polymer compositions, electrophoretic deposition processes using same, and the use of same in forming films on substrates | ROHM AND HAAS COMPANY (US) | 1986-04-02 | — | — | EP | disclosed |
| EP-0062474-B1 | PHOTOSENSITIVE COMPOSITIONS CONTAINING A POLYENE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-02-13 | — | — | EP | disclosed |
| US-4415651-A | UNSATURATED ADDITION POLYMER, A MERCAPTO-CONTAINING CARBOXYLIC ACID AND A PHOTOINITIATORS; LITHOGRAPHY | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-11-15 | — | — | US | disclosed |
| EP-0062474-A1 | Photosensitive compositions containing a polyene | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10507174-B2 | Skin care compositions | CUTA, MMS19, SOD1 | THRB 4745/4885ALDH1A1 1629/4885TP53 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.